Article
Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy.
Journal of viral hepatitis - 1 May 2000
Pradat P, Chossegros P, Bailly F, Pontisso P, Saracco G, Sauleda S, Thursz M, Tillmann H, Vlassopoulou H, Alberti A, Braconier J H, Esteban J I, Hadziyannis S, Manns M, Rizzetto M, Thomas H C, Trépo C
Abstract excerpt
To compare three quantitative assays measuring viral load in patients with chronic hepatitis C and to determine their value in predicting response to interferon (IFN) therapy, we analysed serum from 896 patients from eight European Centres using QUANTIPLEXtrade mark bDNA, MONITOR AMPLICORtrade mark and SUPERQUANTtrade mark assays. Analyses were performed on the same sample. Viral genotype was assessed using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.